Literature DB >> 18035570

Increasing penicillin and trimethoprim-sulfamethoxazole resistance in nasopharyngeal Streptococcus pneumoniae isolates from Guatemalan children, 2001--2006.

Erica L Dueger1, Edwin J Asturias, Jorge Matheu, Remei Gordillo, Olga Torres, Neal Halsey.   

Abstract

OBJECTIVES: We aimed to determine nasopharyngeal colonization rates and antibiotic resistance patterns of Streptococcus pneumoniae isolated from Guatemalan children, and to determine risk factors for colonization and antibiotic nonsusceptibility.
METHODS: Isolates were obtained from children aged 5 to 60 months attending public and private outpatient clinics and daycare centers during August 2001--June 2002 and outpatient clinics during November 2005--February 2006 in Guatemala City. Minimal inhibitory concentrations of penicillin, trimethoprim-sulfamethoxazole (TMS), cefotaxime, and erythromycin were determined using the E-test.
RESULTS: The overall nasopharyngeal colonization rate for S. pneumoniae was 59.1%. From 2001/2 to 2005/6 TMS nonsusceptibility increased from 42.4% to 60.8% (p<0.05) in public clinics and from 51.4% to 84.0% (p=0.009) in private clinics, and penicillin nonsusceptibility increased from 1.5% to 33.3% in public clinics (p<0.001). Reported antibiotic use was not strictly associated with nonsusceptibility to that same antibiotic. Resistance to three or four antibiotics increased in public clinics from 2001/2 (0%) to 2005/6 (10.7%; p<0.001). Risk factors for nasopharyngeal colonization with penicillin- or TMS-nonsusceptible S. pneumoniae were low family income, daycare center attendance, and recent penicillin use.
CONCLUSIONS: Increasing antibiotic nonsusceptibility rates in nasopharyngeal S. pneumoniae isolates from Guatemalan children reflect worldwide trends. Policies encouraging more judicious use of TMS should be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035570      PMCID: PMC2430874          DOI: 10.1016/j.ijid.2007.09.001

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  58 in total

Review 1.  Antimicrobials: modes of action and mechanisms of resistance.

Authors:  Patrick F McDermott; Robert D Walker; David G White
Journal:  Int J Toxicol       Date:  2003 Mar-Apr       Impact factor: 2.032

2.  Bacterial resistance: origins, epidemiology, and impact.

Authors:  David M Livermore
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

3.  Independent risk factors for carriage of penicillin-non-susceptible Streptococcus pneumoniae.

Authors:  Gili Regev-Yochay; Meir Raz; Bracha Shainberg; Ron Dagan; Miriam Varon; Marina Dushenat; Ethan Rubinstein
Journal:  Scand J Infect Dis       Date:  2003

4.  Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.

Authors:  Kelley A Fedler; Douglas J Biedenbach; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2006-08-28       Impact factor: 2.803

5.  Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  Ana Serrão Neto; Paula Lavado; Pedro Flores; Ricardo Dias; Maria Ana Pessanha; Eduarda Sousa; José Martins Palminha; Manuela Caniça; Julieta Esperança-Pina
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431

6.  Indoor air pollution from biomass combustion and acute respiratory illness in preschool age children in Zimbabwe.

Authors:  Vinod Mishra
Journal:  Int J Epidemiol       Date:  2003-10       Impact factor: 7.196

7.  Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance.

Authors:  David J Farrell; Ian Morrissey; Sarah Bakker; Louise Morris; Sylvie Buckridge; David Felmingham
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

8.  Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.

Authors:  George G Zhanel; Lorraine Palatnick; Kimberly A Nichol; Tracy Bellyou; Don E Low; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).

Authors:  C Mendes; M E Marin; F Quiñones; J Sifuentes-Osornio; C Cuilty Siller; M Castanheira; C M Zoccoli; H López; A Súcari; F Rossi; G Barriga Angulo; A J A Segura; C Starling; I Mimica; D Felmingham
Journal:  Braz J Infect Dis       Date:  2003-02       Impact factor: 1.949

10.  Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.

Authors:  Jonathan A Finkelstein; Susan S Huang; James Daniel; Sheryl L Rifas-Shiman; Ken Kleinman; Donald Goldmann; Stephen I Pelton; Alfred DeMaria; Richard Platt
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

View more
  3 in total

1.  Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children.

Authors:  B Quintero; M Araque; C van der Gaast-de Jongh; F Escalona; M Correa; S Morillo-Puente; S Vielma; P W M Hermans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-30       Impact factor: 3.267

2.  In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.

Authors:  Lesley McGee; Donald Biek; Yigong Ge; Magderie Klugman; Mignon du Plessis; Anthony M Smith; Bernard Beall; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

3.  A Solution to Antifolate Resistance in Group B Streptococcus: Untargeted Metabolomics Identifies Human Milk Oligosaccharide-Induced Perturbations That Result in Potentiation of Trimethoprim.

Authors:  Schuyler A Chambers; Rebecca E Moore; Kelly M Craft; Harrison C Thomas; Rishub Das; Shannon D Manning; Simona G Codreanu; Stacy D Sherrod; David M Aronoff; John A McLean; Jennifer A Gaddy; Steven D Townsend
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.